Experimental Strategies for Studying G Protein-Coupled Receptor Homo- and Heteromerization with Radioligand Binding and Signal Transduction Methods

AbdAlla, 2000, AT1-receptor heterodimers show enhanced G protein activation and altered receptor sequestration, Nature, 407, 94, 10.1038/35024095 Alvarez-Curto, 2010, Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors, Analytical and Bioanalytical Chemistry, 398, 167, 10.1007/s00216-010-3823-4 Alvarez-Curto, 2011, Developing chemical genetic approaches to explore G protein-coupled receptor function—Validation of the use of a receptor activated solely by synthetic ligand (RASSL), Molecular Pharmacology, 80, 1033, 10.1124/mol.111.074674 Armstrong, 2001, Dopamine D2 receptor dimer formation: Evidence from ligand binding, The Journal of Biological Chemistry, 276, 22621, 10.1074/jbc.M006936200 Birdsall, 2010, Class A GPCR heterodimers: Evidence from binding studies, Trends in Pharmacological Sciences, 31, 499, 10.1016/j.tips.2010.08.003 Conklin, 1993, Substitution of three amino acids switches receptor specificity of Gqα to that of Giα, Nature, 363, 274, 10.1038/363274a0 Conn, 2007, G protein-coupled receptor trafficking in health and disease: Lessons learned to prepare for therapeutic mutant rescue in vivo, Pharmacological Reviews, 59, 225, 10.1124/pr.59.3.2 Franco, 1996, The cluster-arranged cooperative model: A model that accounts for the kinetics of binding to A1 adenosine receptors, Biochemistry, 35, 3007, 10.1021/bi952415g George, 2000, Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties, The Journal of Biological Chemistry, 275, 26128, 10.1074/jbc.M000345200 Gomes, 2000, Heterodimerization of μ and δ opioid receptors: A role in opiate synergy, The Journal of Neuroscience, 20, RC110, 10.1523/JNEUROSCI.20-22-j0007.2000 Han, 2009, Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation, Nature Chemical Biology, 5, 688, 10.1038/nchembio.199 Jeoung, 2007, Trans-activation, cis-activation and signal selection of gonadotropin receptors, Molecular and Cellular Endocrinology, 260, 137, 10.1016/j.mce.2005.09.015 Jordan, 1999, G protein-coupled receptor heterodimerization modulates receptor function, Nature, 399, 697, 10.1038/21441 Kara, 2010, Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics, Journal of Neurochemistry, 112, 1442, 10.1111/j.1471-4159.2009.06554.x Kasai, 2011, Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging, Biological Chemistry, 192, 463 Maggio, 2007, G protein-coupled receptor oligomerization provides the framework for signal discrimination, Journal of Neurochemistry, 103, 1741, 10.1111/j.1471-4159.2007.04896.x Maggio, 1993, Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular ‘cross-talk’ between G protein-linked receptors, Proceedings of the National Academy of Sciences of the United States of America, 90, 3103, 10.1073/pnas.90.7.3103 McKinney, 1998, Practical aspects of radioligand binding, Current Protocols in Pharmacology, 10.1002/0471141755.ph0103s00 Novi, 2004, The paired activation of the two components of the muscarinic M3 receptor dimer is required for induction of ERK1/2 phosphorylation, The Journal of Biological Chemistry, 279, 7476, 10.1074/jbc.M306818200 Novi, 2005, Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of β-arrestin-1 to the plasma membrane, The Journal of Biological Chemistry, 280, 19768, 10.1074/jbc.M411281200 Pellissier, 2011, G protein activation by serotonin type 4 receptor dimers: Evidence that turning on two protomers is more efficient, The Journal of Biological Chemistry, 286, 9985, 10.1074/jbc.M110.201939 Rios, 2006, μ-Opioid and CB1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neuritogenesis, British Journal of Pharmacology, 148, 387, 10.1038/sj.bjp.0706757 Rozenfeld, 2010, Exploring a role for heteromerization in GPCR signalling specificity, The Biochemical Journal, 433, 11, 10.1042/BJ20100458 Scarselli, 2012, Cell type-specific β2-adrenergic receptor clusters identified using photoactivated localization microscopy are not lipid raft related, but depend on actin cytoskeleton integrity, The Journal of Biological Chemistry, 287, 16768, 10.1074/jbc.M111.329912 Scarselli, 2001, D2/D3 dopamine receptor heterodimers exhibit unique functional properties, The Journal of Biological Chemistry, 276, 30308, 10.1074/jbc.M102297200 Smith, 2010, Allostery at G protein-coupled receptor homo- and heteromers: Uncharted pharmacological landscapes, Pharmacological Reviews, 62, 701, 10.1124/pr.110.002667 Springael, 2006, Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers, Molecular Pharmacology, 69, 1652, 10.1124/mol.105.019414 Strange, 2005, Oligomers of D2 dopamine receptors. Evidence from ligand binding, Journal of Molecular Neuroscience, 26, 155, 10.1385/JMN:26:2-3:155 Vivo, 2006, Investigation of cooperativity in the binding of ligands to the D2 dopamine receptor, Molecular Pharmacology, 69, 226, 10.1124/mol.105.012443 Wreggett, 1995, Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors, The Journal of Biological Chemistry, 270, 22488, 10.1074/jbc.270.38.22488 Zhu, 2005, Heterodimerization of β1- and β2-adrenergic receptor subtypes optimizes β-adrenergic modulation of cardiac contractility, Circulation Research, 97, 244, 10.1161/01.RES.0000176764.38934.86